Compounding Pharmacy · Daphne, AL · 503A

Triad Rx Review

Several GLP-1 telehealth programs name Triad Rx, a Daphne, Alabama 503A, as a state-licensed compounding partner, and it produces compounded semaglutide and tirzepatide. Despite the resemblance, it is a distinct business from Triad Compounding Pharmacy in California.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

503A
Location: Daphne, AL
States licensed: 0
5.0
★★★☆☆2.5/5

Our own score · methodology

Telehealth Brands That Fill Through This Pharmacy

Each brand below has been reported to route some or all of its compounded GLP-1 orders to Triad Rx. Arrangements like these are commercial, and they get changed without announcement.

9.3/ 10
Verified partner

Embody

Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy

★★★★★4.7/5

Editorial score · methodology

$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →
7.4/ 10
Verified partner

MEDGm

Best for: month-to-month compounded semaglutide at $179 with the partner pharmacies named

★★★★☆3.7/5

Editorial score · methodology

$179/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full MEDGm review →
8.4/ 10

Trinity Meds

Best for: compounded semaglutide at $149/month

★★★★☆4.2/5

Editorial score · methodology

$149/mo
SemaglutideTirzepatide
Get StartedRead full Trinity Meds review →
7.6/ 10

altRX

Best for: semaglutide from $1149/month

★★★★☆3.8/5

Editorial score · methodology

$149/mo
CompoundedSemaglutideTirzepatideLegitScript VerifiedFDA Warning
Get StartedRead full altRX review →
7.1/ 10

MEDVi

Best for: knowing which pharmacy fills the vial: it names Triad Rx

★★★★☆3.6/5

Editorial score · methodology

$179/mo
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full MEDVi review →
6.8/ 10

Liv Body

Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy

★★★☆☆3.4/5

Editorial score · methodology

$179/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Liv Body review →
5.7/ 10

Fridays

Best for: coaching bundled into the price rather than sold separately

★★★☆☆2.9/5

Editorial score · methodology

$249/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Fridays review →

Accreditations and Standards

Sterile compounding in this country runs on one rulebook, General Chapter <797> of the United States Pharmacopeia[4]. Depending on what is being made, the finished preparation is then tested for sterility under USP <71>[5] and for bacterial endotoxins under USP <85>[6]. Every pharmacy on this page owes those standards already. What follows is what this one has added on top.

Past the state pharmacy license, we could not verify any outside accreditation for this pharmacy.

What It Compounds

Whether any pharmacy may compound semaglutide or tirzepatide at all turns on where the reference product sits on the FDA Drug Shortage List. When a drug comes off that list the door closes, and it has closed before[7].

Semaglutide
Compounds semaglutide
Tirzepatide
Compounds tirzepatide

States Licensed

Triad Rx publishes no state-by-state licensure list, so we cannot tell you whether it is licensed where you live. Put that question to your own state board of pharmacy before you fill anything here.

What Regulators Have on File

Our records hold no public FDA enforcement action and no recall against Triad Rx. Read that as the edge of what we found rather than as a clearance. Enforcement arrives after the fact, so check with the FDA, and with your own state board, yourself.

How GLP Watchdog Scored This Pharmacy

Accreditation held6/10
Standing with regulators9/10
States licensed0/10
GLP-1 compounding10/10
Years operating5/10

We research every score ourselves. The methodology page sets out how each part is weighted.

Medium confidence · Last verified 2026-07-16 via research · How we check provider data

Frequently Asked Questions

Here is what we can and cannot confirm. Triad Rx operates as a 503A compounding pharmacy out of Daphne, AL. Its authority to operate rests on a state board of pharmacy license and nothing further. No recent public FDA enforcement action has reached our records, and that is not the same as none existing. Enforcement history moves, so put the current standing to your state board of pharmacy before you fill anything.
Triad Rx works out of Daphne, AL. We have not recorded its state license list, which is not the same as it holding none — confirm shipping to your state with the pharmacy or your state board.
Alongside its other compounded preparations, Triad Rx makes compounded semaglutide and compounded tirzepatide. Being a 503A pharmacy, it compounds only against a prescription written for one named patient, with the state board of pharmacy watching.
Two things separate them: who inspects, and how much may be made at once. A 503B outsourcing facility registers with the FDA itself, works to current Good Manufacturing Practices (cGMP), submits to FDA inspection, and may make compounded medication in batches with no named patient attached. A 503A pharmacy cannot do that. It fills a prescription written for one patient, answers mainly to its state board of pharmacy, and works to the USP <797> standard for sterile compounding. Neither route produces an FDA-approved drug.

Glossary

The words sellers use, defined. Tap any term.

Sources & methodology — as of September 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.